Currently, the Merieux Alliance group is the majority shareholder of the BioMerieux group with 58.9% of the capital. Then comes the Dassault family with 5.10% of the capital, Jupiter Asset Management with 4.62% of the shares, Sofina with 2.12% of the capital, Oddo Bhf Aset management with 1.68%, Capital Research & Management with 1.33% of the shares, Norges bank Investment management with 1.29%, The Vanguard Group with 0.95%, BlackRock Fund Advisors with 0.62% and finally Candtriam Belgium with 0.61%.